会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Liquid crystalline polymers
    • 液晶聚合物
    • US06465002B1
    • 2002-10-15
    • US09523887
    • 2000-03-13
    • Edith MathiowitzJules S. JacobYong S. JongDonald E. Chickering, IIIEdwin E. Edwards
    • Edith MathiowitzJules S. JacobYong S. JongDonald E. Chickering, IIIEdwin E. Edwards
    • A61F1300
    • C09K19/38B29C55/00B29C55/18B29K2105/0079
    • Methods for inducing a thermoplastic polymer, which can be non-mesogenic, to exhibit liquid crystalline properties have been developed. The method includes the steps of (a) heating the polymer from an initial temperature below its glass transition temperature (Tg) to a temperature greater than its Tg and below its melting temperature (Tm); (b) exposing the polymer to a pressure greater than about 2 metric tons/in2, preferably between about 2 and 10 metric tons/in2, preferably for at least about one minute, while maintaining the temperature greater than its Tg; and (c) cooling the polymer below the Tg while maintaining the elevated pressure. Unlike many prior art transition processes which are reversible, this process provides a liquid crystal state that can be maintained for years at ambient conditions. In a preferred embodiment, the plastics are bioerodible thermoplastic polymers, such as polyanhydrides, some polyesters, polyamides, and polyaromatics. The liquid crystalline polymers can be used in the controlled release or retention of substances encapsulated in the polymers. The polymer can be in a variety of forms including films, film laminants, and microparticles. In a preferred embodiment, the LC polymers are used to encapsulate therapeutic, diagnostic, or prophylactic agents for use in medical or pharmaceutical applications.
    • 已经开发了用于诱导可以是非介晶的热塑性聚合物以显示液晶性质的方法。 该方法包括以下步骤:(a)将聚合物从低于其玻璃化转变温度(Tg)的初始温度加热至大于其Tg并低于其熔融温度(Tm)的温度; (b)将聚合物暴露于大于约2公吨/ in2的压力下,优选约2至10公吨/ in 2,优选至少约1分钟,同时保持温度高于其Tg; 和(c)在保持升高的压力的同时将聚合物冷却至Tg以下。 与可逆的许多现有技术的过渡过程不同,该方法提供可在环境条件下保持多年的液晶状态。 在优选的实施方案中,塑料是可生物腐蚀的热塑性聚合物,例如聚酐,一些聚酯,聚酰胺和多芳族化合物。 液晶聚合物可用于控制或保留包封在聚合物中的物质。 聚合物可以是各种形式,包括膜,膜层压剂和微粒。 在优选的实施方案中,LC聚合物用于包封用于医疗或药物应用的治疗剂,诊断剂或预防剂。
    • 6. 发明授权
    • Bioadhesive microspheres and their use as drug delivery and imaging systems
    • 生物粘附微球及其作为药物递送和成像系统的用途
    • US06365187B2
    • 2002-04-02
    • US09773229
    • 2001-01-31
    • Edith MathiowitzDonald E. Chickering, IIIJules Serge Jacob
    • Edith MathiowitzDonald E. Chickering, IIIJules Serge Jacob
    • A61K914
    • A61K9/1641A61K9/167Y10S514/962Y10S977/906Y10S977/915Y10S977/928
    • Bioadhesive polymers in the form of, or as a coating on, microcapsules containing drugs or bioactive substances which may serve for therapeutic, or diagnostic purposes in diseases of the gastrointestinal tract, are described. The polymeric microspheres all have a bioadhesive force of at least 11 mN/cm2 (110 N/m2) Techniques for the fabrication of bioadhesive microspheres, as well as a method for measuring bioadhesive forces between microspheres and selected segments of the gastrointestinal tract in vitro are also described. This quantitative method provides a means to establish a correlation between the chemical nature, the surface morphology and the dimensions of drug-loaded microspheres on one hand and bioadhesive forces on the other, allowing the screening of the most promising materials from a relatively large group of natural and synthetic polymers which, from theoretical consideration, should be used for making bioadhesive microspheres.
    • 描述了可以用作胃肠道疾病中的治疗或诊断目的的药物或生物活性物质的形式或作为包衣形式的生物粘附聚合物。 聚合物微球全部具有至少11mN / cm 2(110N / m 2)的生物附着力。用于制造生物粘附性微球的技术以及用于测量微球和体外胃肠道选定区段之间的生物粘附力的方法是 也描述。 这种定量方法提供了一种手段来建立化学性质,表面形态和药物负载微球的尺寸与生物粘附力之间的相关性,另一方面可以从相对较大的组中筛选出最有希望的材料 天然和合成的聚合物,从理论上考虑,应用于制造生物粘附微球。
    • 9. 发明授权
    • Methods and compositions for enhancing the bioadhesive properties of
polymers using organic excipients
    • 使用有机赋形剂增强聚合物生物粘合性能的方法和组合物
    • US06156348A
    • 2000-12-05
    • US135248
    • 1998-08-17
    • Camila A. SantosJules S. JacobBenjamin A. HertzogGerardo P. CarinoEdith Mathiowitz
    • Camila A. SantosJules S. JacobBenjamin A. HertzogGerardo P. CarinoEdith Mathiowitz
    • B82B1/00A61K9/16A61K9/51A61K9/50A61F2/02A61K47/30
    • A61K9/5138A61K9/1641A61K9/1647A61K9/5153
    • Methods and compositions are provided for enhancing the bioadhesive properties of polymers used in drug delivery systems. The bioadhesive properties of a polymer are enhanced by incorporating an anhydride oligomer into the polymer to enhance the ability of the polymer to adhere to a tissue surface such as a mucosal membrane. Anhydride oligomers which enhance the bioadhesive properties of a polymer include oligomers synthesized from dicarboxylic acid monomers, preferably those found in Krebs glycolysis cycle, especially fumaric acid. The oligomers can be incorporated within a wide range of polymers including proteins, polysaccharides and synthetic biocompatible polymers. In one embodiment, anhydride oligomers can be incorporated within polymers used to form or coat drug delivery systems, such as microspheres, which contain a drug or diagnostic agent. The oligomers can either be solubilized and blended with the polymer before manufacture or else used as a coating with polymers over existing systems. The polymers, for example in the form of microspheres, have improved ability to adhere to mucosal membranes, and thus can be used to deliver a drug or diagnostic agent via any of a range of mucosal membrane surfaces including those of the gastrointestinal, respiratory, excretory and reproductive tracts.
    • 提供了用于增强药物递送系统中使用的聚合物的生物粘合性质的方法和组合物。 聚合物的生物粘合性能通过将酸酐低聚物引入聚合物来增强聚合物粘附到组织表面如粘膜的能力。 增强聚合物生物粘合性能的酸酐低聚物包括由二羧酸单体合成的低聚物,优选在克雷伯糖酵解循环中发现的那些,特别是富马酸。 低聚物可以掺入宽范围的聚合物中,包括蛋白质,多糖和合成的生物相容性聚合物。 在一个实施方案中,酸酐低聚物可以掺入用于形成或涂覆药物递送系统的聚合物,例如含有药物或诊断剂的微球体。 寡聚物可以在制造之前溶解并与聚合物共混,或者在现有体系中用作具有聚合物的涂层。 聚合物,例如以微球形式,具有改善粘附于粘膜的能力,因此可用于通过任何一种粘膜膜表面(包括胃肠道,呼吸道,排泄物)的粘膜递送药物或诊断剂 和生殖道。
    • 10. 发明授权
    • Liquid crystalline polymers
    • 液晶聚合物
    • US06696075B2
    • 2004-02-24
    • US10231723
    • 2002-08-30
    • Edith MathiowitzJules S. JacobYong S. JongDonald E. ChickeringEdwin E. Edwards
    • Edith MathiowitzJules S. JacobYong S. JongDonald E. ChickeringEdwin E. Edwards
    • A61F1300
    • C09K19/38B29C55/00B29C55/18B29K2105/0079
    • Methods for inducing a thermoplastic polymer, which can be non-mesogenic, to exhibit liquid crystalline properties have been developed. The method includes the steps of (a) heating the polymer from an initial temperature below its glass transition temperature (Tg) to a temperature greater than its Tg and below its melting temperature (Tm); (b) exposing the polymer to a pressure greater than about 2 metric tons/in2, preferably between about 2 and 10 metric tons/in2, preferably for at least about one minute, while maintaining the temperature greater than its Tg; and (c) cooling the polymer below the Tg while maintaining the elevated pressure. Unlike many prior art transition processes which are reversible, this process provides a liquid crystal state that can be maintained for years at ambient conditions. In a preferred embodiment, the plastics are bioerodible thermoplastic polymers, such as polyanhydrides, some polyesters, polyamides, and polyaromatics. The liquid crystalline polymers can be used in the controlled release or retention of substances encapsulated in the polymers. The polymer can be in a variety of forms including films, film laminants, and microparticles. In a preferred embodiment, the LC polymers are used to encapsulate therapeutic, diagnostic, or prophylactic agents for use in medical or pharmaceutical applications.
    • 已经开发了用于诱导可以是非介晶的热塑性聚合物以显示液晶性质的方法。 该方法包括以下步骤:(a)将聚合物从低于其玻璃化转变温度(Tg)的初始温度加热至大于其Tg并低于其熔融温度(Tm)的温度; (b)将聚合物暴露于大于约2公吨/ in 2的压力下,优选在约2至10公吨/ in 2之间,优选至少约1分钟,同时保持温度高于其 Tg; 和(c)在保持升高的压力的同时将聚合物冷却至Tg以下。 与可逆的许多现有技术的过渡过程不同,该方法提供可在环境条件下保持多年的液晶状态。 在优选的实施方案中,塑料是可生物腐蚀的热塑性聚合物,例如聚酐,一些聚酯,聚酰胺和多芳族化合物。 液晶聚合物可用于控制或保留包封在聚合物中的物质。 聚合物可以是各种形式,包括膜,膜层压剂和微粒。 在优选的实施方案中,LC聚合物用于包封用于医疗或药物应用的治疗剂,诊断剂或预防剂。